Cyclopharm

Cyclopharm PP&E per Employee

The PP&E per Employee of Cyclopharm (CYC.AX) as of Nov 3, 2026 is 372,133.89 AUD. In the previous year, PP&E per Employee was 363,884.17 AUD — a change of 2.27% (higher).

PP&E per Employee

372,133.89AUD

YoY

2.27%

Last updated:

PP&E per Employee of Cyclopharm is 2025 372,133.89 AUD. PP&E per Employee of Cyclopharm was 2024 363,884.17 AUD. It decreases by 2.27% higher compared to the previous year.

The Cyclopharm PP&E per Employee history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

PP&E per Employee
Date
PP&E per Employee
Jan 1, 2018
68,566.83 AUD
Jan 1, 2019
174,410.69 AUD
Jan 1, 2020
161,515.58 AUD
Jan 1, 2021
173,495.89 AUD
Jan 1, 2022
183,322.22 AUD
Jan 1, 2023
255,172.22 AUD
Jan 1, 2024
363,884.17 AUD
Jan 1, 2025
372,133.89 AUD
The Cyclopharm PP&E per Employee history
YEARPP&E per EmployeeYoY
372,133.89AUD+2.27%
363,884.17AUD+42.60%
255,172.22AUD+39.19%
183,322.22AUD+5.66%
173,495.89AUD+7.42%
161,515.58AUD-7.39%
174,410.69AUD+154.37%
68,566.83AUD-7.98%
74,511.75AUD+14.60%
65,018.19AUD+270.53%
17,547.50AUD-13.35%
20,250.00AUD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cyclopharm Stock analysis

What does Cyclopharm do? Cyclopharm Ltd is an Australian company that was founded in 1986 and has since been developing innovative medical solutions. The company operates in the field of nuclear medicine and focuses on providing diagnostic and therapeutic products and services. The history of Cyclopharm Ltd began with the development of the Technetium-99m generator, an instrument for generating radioisotopes that can be used in medical imaging. Since then, the company has expanded its offerings and now offers a wide range of products and services. Cyclopharm Ltd's business model is based on research and development of new solutions based on the needs of the medical community and patients. The company works closely with doctors, scientists, and other experts to ensure that its products and services meet the highest standards. Cyclopharm Ltd is divided into various divisions to coordinate and optimize its activities. These include diagnostics, therapy, research and development, as well as sales and marketing. Each division works closely with the others to ensure that the company achieves its goals and provides optimal customer care. Some of Cyclopharm Ltd's most well-known products include the Technetium-99m generator and the radiopharmaceutical Technegas. Technegas is a gas used for lung imaging and plays an important role in diagnosing lung problems. The radiopharmaceutical is produced using the Technetium-99m generator and is an important addition to medical imaging. In addition, Cyclopharm Ltd also develops therapeutic solutions that can be used to treat cancer and other diseases. These include radiopharmaceuticals used in radiation therapy, as well as other solutions tailored to the individual needs of patients. Cyclopharm Ltd is also actively working on improving and expanding its products and services. The company invests in research and development to develop innovative solutions that can improve medical imaging and therapy. Additionally, the company works closely with its customers to better understand their needs and offer them tailored solutions. Overall, Cyclopharm Ltd is an innovative and goal-oriented company that focuses on providing diagnostic and therapeutic solutions in the field of nuclear medicine. The company has a long history of leadership in this field and will continue to be at the forefront of developing solutions that improve the lives of patients and medical professionals. Cyclopharm is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Cyclopharm stock

PP&E per Employee of Cyclopharm is 372,133.89 AUD in 2025.

PP&E per Employee of Cyclopharm changed from 363,884.17 AUD to 372,133.89 AUD, representing a 2.27% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of PP&E per Employee Cyclopharm since 2006 – with annual values, charts, and detailed analysis.

PP&E per employee measures the physical capital intensity per worker. Higher values indicate more capital-intensive operations.

PP&E per Employee's AUD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track PP&E per Employee's Cyclopharm historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Workforce — Cyclopharm

All Key Metrics — Cyclopharm